Citinip P 500mg/800mg Tablet
By Citinip P
Rx
10 Tablet in a Strip

Composition
Citicoline(500mg) + Piracetam(800mg)

Manufacturer - Dhamus Pharma
Katra Sher Singh Shop No 1-2 Harman Market Katra Sher Singh Amritsar Amritsar, Punjab 143001 India

Expires on or after
October, 2025

liver
Citinip P 500mg/800mg Tablet is considered safe for patients with liver disease. The available data indicates that adjusting the dosage of Citinip P 500mg/800mg Tablet may not be necessary for individuals with liver conditions. It is recommended to consult your doctor if you have liver impairment or any related concerns before using this medication.

kidney
Citinip P 500mg/800mg Tablet should be used cautiously in patients with kidney disease. Dose adjustment may be necessary, especially for those with kidney impairment. It is not recommended for patients with severe kidney disease. Please consult your doctor for guidance.

alcohol
Caution Avoid alcohol with Citinip P 500mg/800mg Tablet Tablet as it may cause increased drowsiness. Consult your doctor.

driving
Caution should be taken when driving after taking Citinip P 500mg/800mg Tablet, as it may cause drowsiness, nervousness, and shakiness. These side effects could impair your focus and reaction time while driving. Avoid driving or operating machinery if affected.

pregnancy
It is better to consult your doctor before using Citinip P 500mg/800mg Tablet.

breastfeeding
It is better to consult your doctor before using Citinip P 500mg/800mg Tablet during breastfeeding, as there is no specific safety information available. Your doctor will determine if it is safe for breastfeeding mothers to take this medication.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹585
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024